Streetbeat News

Stock Prices

TIVC

Tivic Health Systems, Inc. (NASDAQ:TIVC) has announced the pricing of its public offering of 32.5 million shares at $0.055 per share, expecting to raise approximately $1.8 million before fees and expenses. The proceeds will be used for working capital and general corporate purposes. The offering is expected to close on July 11, 2023.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 12:42 pm

CAH

CDNA

CMPS

NERV

SIEN

The article lists five health care stocks that are considered overbought and may collapse this quarter. These include Sientra, Inc. (SIEN), CareDx, Inc (CDNA), COMPASS Pathways plc (CMPS), Minerva Neurosciences, Inc. (NERV), and Cardinal Health, Inc. (CAH). The Relative Strength Index (RSI) of these stocks is above 70, indicating they are overbought.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:33 pm

FANG

LYV

META

RIG

On CNBC's 'Halftime Report Final Trades', several stocks were recommended. Josh Brown of Ritholtz Wealth Management recommended Live Nation Entertainment (LYV), citing an uptrend and a recent price target increase by Citigroup. Kevin Simpson named Home Depot (HD) as his final trade, despite the company's recent settlement of a lawsuit for underpaying workers. Bryn Talkington of Requisite Capital Management recommended Diamondback Energy (FANG) as energy stocks traded higher. Jim Lebenthal of Cerity Partners picked Transocean Ltd. (RIG) following an upgrade by Citigroup. Stephen Weiss of Short Hills Capital Partners named Meta Platforms (META) as his final trade, following the launch of Threads, a platform similar to Twitter.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:24 pm

MRNA

NFLX

ORCL

TSLA

Insiders at Tesla, Moderna, Oracle, and Netflix have recently sold shares. Tesla's CFO sold 3,750 shares, Moderna's Director sold 15,000 shares, Oracle's Chief Accounting Officer sold 5,000 shares, and Netflix's Director sold 46,057 shares. The reasons for these sales are not clear, but they could be preplanned or due to concerns about the companies' prospects or overpricing.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:23 pm

HELE

Helen Of Troy Ltd (NASDAQ:HELE) reported a Q1 FY24 sales decline of 6.6% YoY to $474.67 million, beating the analyst consensus of $465.36 million. The decrease was primarily due to lower sales in several categories. Adjusted EPS of $1.94 beat the analyst consensus of $1.60. The company continues its global restructuring plan, Project Pegasus, to improve efficiency and reduce costs. Helen Of Troy expects FY24 revenue of $1.965 billion - $2.015 billion against the consensus of $2 billion. HELE shares are trading higher by 9.29% at $123.00 in premarket.

Portfolio Pulse from Shivani Kumaresan

July 10, 2023 | 12:16 pm

BHC

IEP

ILMN

XRX

Carl Icahn, activist investor, has been struggling to recover after a short-seller attack led to a 40% drop in his investment company's shares, Icahn Enterprises L.P. (NASDAQ:IEP). Icahn and the banks that loaned him money have finalized amended loan agreements, disconnecting his personal loans from the trading price of his company's shares. Icahn owns approximately 85% of IEP, worth $18 billion before the report and $10.7 billion as of Friday. IEP's holdings include Illumina Inc (NASDAQ: ILMN), Xerox Holdings Corporation (NASDAQ: XRX), and Bausch Health Companies Inc (NYSE: BHC).

Portfolio Pulse from Vandana Singh

July 10, 2023 | 12:15 pm

ALPP

NBTX

NEON

TIVC

Several stocks experienced significant movement in pre-market trading. Notable gainers include Nanobiotix S.A. (NBTX), which surged 59.3% after entering a license agreement with Janssen Pharmaceutical, and Alpine 4 Holdings, Inc. (ALPP), which gained 29.2% after its subsidiary received a $5.25m purchase order from a U.S. Government contractor. On the other hand, Neonode Inc. (NEON) and Tivic Health Systems, Inc. (TIVC) were among the biggest losers, falling 30.4% and 23.3% respectively.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:11 pm

BABA

Alibaba Group Holding Limited (NYSE:BABA) is considering selling shares of Ant Group back to the fintech company, which has proposed a $6 billion share repurchase program. Alibaba, which holds a 33% stake in Ant, proposes to transfer any repurchased shares into the fintech company's employee incentive plan. Ant Group's valuation has declined by nearly 70% compared to its market capitalization during its IPO, which China scrapped in 2020. The company faces challenges in regaining its former valuation and operations despite the regulatory crackdown ending.

Portfolio Pulse from Anusuya Lahiri

July 10, 2023 | 12:11 pm

URGN

UroGen Pharma Ltd. (NASDAQ:URGN) has published the results of a sub-analysis from the first post-commercial utilization review of JELMYTO (mitomycin) for pyelocalyceal solution. The study assessed the efficacy of JELMYTO in managing patients with larger volume disease where initial tumor burden may not be amenable to complete mechanical ablation or renal preservation.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 12:08 pm

IZEA

IZEA Worldwide has regained compliance with the Nasdaq Bid Price Rule, which requires listed companies to maintain a minimum bid price of $1.00 per share.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 12:06 pm